We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Contributions |

Ecology of the Aging Human Brain

Joshua A. Sonnen, MD; Karen Santa Cruz, MD; Laura S. Hemmy, PhD; Randall Woltjer, MD, PhD; James B. Leverenz, MD; Kathleen S. Montine, PhD; Clifford R. Jack, MD; Jeffrey Kaye, MD; Kelvin Lim, MD; Eric B. Larson, MD, MPH; Lon White, MD, MPH; Thomas J. Montine, MD, PhD
Arch Neurol. 2011;68(8):1049-1056. doi:10.1001/archneurol.2011.157.
Text Size: A A A
Published online

Background Alzheimer disease, cerebral vascular brain injury, and isocortical Lewy body disease (LBD) are the major contributors to dementia in community- and population-based studies.

Objective To estimate the prevalence of clinically silent forms of these diseases in cognitively normal (CN) adults.

Design Autopsy study.

Setting Community- and population based.

Participants A total of 1672 brain autopsies from the Adult Changes in Thought study, Honolulu-Asia Aging Study, Nun Study, and Oregon Brain Aging Study, of which 424 met the criteria for CN.

Main Outcome Measures Of these, 336 cases had a comprehensive neuropathologic examination of neuritic plaque density, Braak stage for neurofibrillary tangles, LB distribution, and number of cerebral microinfarcts.

Results Forty-seven percent of CN cases had moderate or frequent neuritic plaque density; of these, 6% also had Braak stage V or VI for neurofibrillary tangles. Fifteen percent of CN cases had medullary LBD; 8% also had nigral and 4% isocortical LBD. The presence of any cerebral microinfarcts was identified in 33% and of high-level cerebral microinfarcts in 10% of CN individuals. Overall, the burden of lesions in each individual and their comorbidity varied widely within each study but were similar across studies.

Conclusions These data show an individually varying complex convergence of subclinical diseases in the brain of older CN adults. Appreciating this ecology should help guide future biomarker and neuroimaging studies and clinical trials that focus on community- and population-based cohorts.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal


Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Brain autopsy results from 336 cognitively normal individuals expressed as summary neuropathology scores (range, 0-9) ranked from lowest to highest. Each stacked bar shows an individual's burden of Alzheimer disease (AD) (blue), Lewy body disease (LBD) (green), and microvascular brain injury (μVBI) (red). A, One hundred sixteen Adult Changes in Thought study (ACT) participants. B, One hundred six Nun Study (NS) participants. C, Fifty-nine Honolulu-Asia Aging Study (HAAS) participants. D, Fifty-five Oregon Brain Aging Study (OBAS) participants.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Cumulative relative frequency of the summary neuropathology score for autopsied individuals with complete neuropathologic examination from the 4 studies who were cognitively normal (CN) as defined in Table 1 (n = 336); those with lower cognitive function (LCF), defined as individuals last evaluated within 2 years of death at which time they were diagnosed as not having dementia but scored in the lowest quintile on the cognitive screening test (n = 189); and those who were diagnosed as having dementia (n = 522). Nonparametric analysis of variance comparing summary neuropathology scores among the 3 groups had P < .001 and the Dunn corrected multiple paired comparisons had P < .001 for CN vs LCF, LCF vs dementia, and CN vs dementia.




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination
Make the Diagnosis: Will This Patient Fall?

The Rational Clinical Examination
Original Article: Will This Patient Fall?